Our mission is to become a transnational pharmaceutical company through the development and introduction of a wide portfolio of branded and generic products in key markets.
Customer Notification: Product Theft Update
GENERICS
Lupin Pharmaceuticals, Inc. entered the U.S. generic pharmaceutical market in 2003 with the ANDA approval for cefuroxime axetil.
SPECIALTY
We are very pleased to be able to bring Suprax® an important anti-infective product in pediatric practice, back to the US market.
API
We are recognized as a leading manufacturer of cephalosporin API’s, with FDA approval to manufacture complex oral and injectable cephalosporins.
For Aerochamber Plus® information, go to the following website link:
http://www.Aerochambervhc.com
LUPIN
Lupin is amongst the world's largest manufacturers of products in its chosen therapeutic areas.
Lupin receives FDA approval for Famotidine for Oral Suspension
Lupin receives FDA approval for Imipramine Pamoate Capsules
Lupin receives FDA tentative approval for Eszopiclone tablets
Lupin is granted USFDA approval for Levetiracetam Tablets
Lupin receives USFDA approval for Divalproex Sodium Delayed-Release Tablets
Lupin appoints New NCE Research Head.
Copyright © 2006. All rights reserved.
Created and Designed by
Gayatri Microsystems